Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.
Skip to main content

Take part in our research

enquires@ndcn.ox.ac.uk

What's new

Gene therapy shows promise in tackling common cause of childhood blindness

The results of a first-in-human clinical trial of gene therapy to treat a common cause of genetic blindness have shown partial reversal of sight loss in some patients.

Gift boosts research into UK’s biggest cause of sight loss

£277,000 from the estate of Jean Williams will support cutting-edge studies into macular disease, which affects nearly 1.5 million people.

Improving epilepsy treatment in Africa

The NIHR Research and Innovation for Global Health Transformation (RIGHT) programme has awarded £4.9 million to help fund a project investigating epilepsy in sub-Saharan Africa.

Our researchers test ‘Viagra’ drug to prevent recurrent strokes

Researchers in our Centre for the Prevention of Stroke and Dementia have begun a clinical trial to assess whether the drug sildenafil could improve blood flow to the brain.